体外式膜酸素供給システム市場 - 世界の産業規模、シェア、動向、機会、予測、モダリティ別、用途別、エンドユーザー別、地域別、競合別、2020年～2030年

体外式膜酸素供給（ECMO）システムの世界市場は、2024年に5億7,120万米ドルと評価され、予測期間には7億8,248万米ドルに達すると予測され、2030年までのCAGRは5.36%です。

体外式膜酸素供給（ECMO）システム市場は、クリティカルケア環境における高度な生命維持技術に対する需要の高まりにより、大きく拡大しています。ECMOシステムは、長時間の体外循環と酸素供給を提供することで、重症心不全や呼吸不全の患者の管理に重要な役割を果たしています。生存率向上におけるECMOの有効性に関するヘルスケア専門家の意識の高まりが、ECMOの普及に寄与しています。リアルタイムのモニタリング、コンパクトな設計、自動化などの革新的な機能の統合により、システムの性能と使いやすさがさらに向上しています。心血管疾患、呼吸器疾患、臓器不全の症例が増加していることが、特に集中治療室（ICU）や心臓専門センターにおけるECMOの必要性を高めています。医療技術の進歩も患者の転帰を改善し、ECMOを生命を脅かす病態への好ましい介入にしています。

ECMO技術の進歩により、ポータブルで使いやすいシステムの開発が進んでいます。研究開発への投資の増加により、効率が向上し、合併症が減少し、患者の安全性が向上した機器が開発されています。低侵襲で経皮的なECMOカニュレーション技術が好まれるようになったことで、手技のリスクが軽減され、従来の病院環境以外にもECMOの適用範囲が広がっています。心臓や肺の移植手術の増加も、周術期のサポートにECMOの使用を必要とし、市場の成長をさらに促進しています。人工知能（AI）とデータ分析の統合は、臨床医がECMOのパフォーマンスをモニターして最適化するのに役立ち、より良い患者管理につながっています。先進諸国における好意的な償還政策がECMO療法への患者のアクセスを向上させている一方、新生児および小児医療への注目の高まりが対象患者を拡大しています。ヘルスケアプロバイダーと医療機器メーカーのコラボレーションは、特に重症患者医療インフラが急速に発展している新興国市場で、ECMOシステムの採用を加速させています。

主要な市場促進要因

医療技術の進歩

主要な市場課題

高コストと資源集約度

主要な市場動向

技術の進歩と小型化

目次

第1章 製品概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 体外式膜酸素供給（ECMO）システムの世界市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • モダリティ別（動脈静脈（VA）、静脈静脈（VV）、その他）
  • 用途別（呼吸器用途、心臓用途、体外心肺蘇生（ECPR））
  • エンドユーザー別（病院・診療所、外来診療センター、その他）
  • 地域別
  • 企業別（2024年）
• 市場マップ

第6章 北米の体外式膜酸素供給（ECMO）システム市場の見通し

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の体外式膜酸素供給（ECMO）システム市場の見通し

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン

第8章 アジア太平洋の体外式膜酸素供給（ECMO）システム市場の見通し

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米の体外式膜酸素供給（ECMO）システム市場の見通し

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの体外式膜酸素供給（ECMO）システム市場の見通し

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因・課題

第12章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第13章 世界の体外式膜酸素供給（ECMO）システム市場：SWOT分析

第14章 競合情勢

• LivaNova (Alung Technologies Inc.)
• Eurosets
• Getinge AB
• Medtronic PLC
• Microport Scientific Corporation
• Nipro Medical Corporation
• Terumo Medical Corporation
• Abbott Laboratories
• Fresenius Medical Care Company

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Extra Corporeal Membrane Oxygenation (ECMO) System Market was valued at USD 571.20 Million in 2024 and is expected to reach USD 782.48 Million in the forecast period with a CAGR of 5.36% through 2030. The Extracorporeal Membrane Oxygenation (ECMO) System Market is experiencing significant expansion due to the growing demand for advanced life-support technologies in critical care settings. ECMO systems play a crucial role in managing patients with severe cardiac and respiratory failure by providing prolonged extracorporeal circulation and oxygenation. Increased awareness among healthcare professionals regarding the effectiveness of ECMO in improving survival rates has contributed to its widespread adoption. The integration of innovative features such as real-time monitoring, compact designs, and automation is further enhancing system performance and usability. Rising cases of cardiovascular diseases, respiratory disorders, and organ failure are driving the need for ECMO, particularly in intensive care units (ICUs) and specialized cardiac centers. Advancements in medical technologies are also improving patient outcomes, making ECMO a preferred intervention in life-threatening conditions.

Advancements in ECMO technology are reshaping the market, leading to the development of portable and user-friendly systems. Increasing investments in research and development have resulted in devices with enhanced efficiency, reduced complications, and improved patient safety. The growing preference for minimally invasive and percutaneous ECMO cannulation techniques has reduced procedural risks and expanded the applicability of ECMO beyond traditional hospital settings. An increasing number of heart and lung transplant procedures also necessitate the use of ECMO for perioperative support, further driving market growth. The integration of artificial intelligence (AI) and data analytics is helping clinicians monitor and optimize ECMO performance, leading to better patient management. Favorable reimbursement policies in developed countries are enhancing patient access to ECMO therapy, while the growing focus on neonatal and pediatric care is expanding the target patient population. Collaborations between healthcare providers and medical device manufacturers are accelerating the adoption of ECMO systems, particularly in emerging markets where critical care infrastructure is rapidly developing.

Key Market Drivers

Advancements in Medical Technology

Advancements in medical technology have significantly enhanced extracorporeal membrane oxygenation (ECMO) systems, improving their efficacy, safety, and overall utility. These innovations are particularly crucial given the rising prevalence of cardiovascular diseases (CVDs) and respiratory failures, which are leading causes of mortality globally.

In the United States, heart disease remains the leading cause of death, accounting for 702,880 fatalities in 2022, which represents 1 in every 5 deaths. Coronary heart disease (CHD) is the most common type, responsible for 371,506 deaths in the same year. Additionally, about 1 in 20 adults aged 20 and older have CHD. Each year, approximately 805,000 Americans experience a heart attack, with 605,000 being first occurrences and 200,000 happening in individuals who have already had a heart attack.

Key Market Challenges

High Costs and Resource Intensity

ECMO therapy is a highly specialized and resource-intensive medical intervention. The equipment itself is expensive, and the overall cost of ECMO treatment includes not only the machine but also the required disposables, personnel, and infrastructure. Running an ECMO program demands a skilled team of healthcare professionals, including perfusionists and specially trained nurses, as well as dedicated facilities with the necessary technology and expertise.

Financial Burden: The high upfront costs associated with establishing and maintaining an ECMO program can be a substantial financial burden for healthcare institutions, particularly smaller hospitals and clinics. Due to the resource-intensive nature of ECMO, it may not be readily available in all healthcare settings, limiting access for patients in remote areas or regions with fewer healthcare resources. The cost barrier can exacerbate healthcare disparities, as not all patients may have equal access to ECMO treatment, potentially leading to unequal outcomes based on socioeconomic factors.

Key Market Trends

Technological Advancements and Miniaturization

One prominent trend in the global ECMO System Market is the continuous advancement of technology and the development of more compact, portable ECMO systems. This trend aims to make ECMO therapy more accessible and versatile.

Miniaturized ECMO Machines: Manufacturers are working on creating smaller, more portable ECMO machines that are easier to transport and set up. This makes ECMO treatment feasible in a wider range of healthcare settings, including ambulances and remote clinics. ECMO systems are increasingly being integrated with advanced monitoring devices and artificial intelligence algorithms. This integration allows for real-time monitoring of patient vitals, helping healthcare providers make informed decisions and detect complications earlier. Some ECMO systems now offer wireless connectivity, enabling healthcare teams to monitor patients remotely. This feature is especially valuable for critical care patients who require continuous monitoring even during inter-hospital transfers.

Key Market Players

• LivaNova (Alung Technologies Inc.)
• Eurosets
• Getinge AB
• Medtronic PLC
• Microport Scientific Corporation
• Nipro Medical Corporation
• Terumo Medical Corporation
• Abbott Laboratories
• Fresenius Medical Care Company

Report Scope:

In this report, the Global Extra Corporeal Membrane Oxygenation (ECMO) System Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Extra Corporeal Membrane Oxygenation (ECMO) System Market, By Modality:

• Veno-Arterial (VA)
• Veno-Venous (VV)
• Others

Extra Corporeal Membrane Oxygenation (ECMO) System Market, By Application:

• Respiratory Applications
• Cardiac Applications
• Extracorporeal Cardiopulmonary Resuscitation (ECPR)

Extra Corporeal Membrane Oxygenation (ECMO) System Market, By End-User:

• Hospitals & Clinics
• Ambulatory Care Centers
• Others

Extra Corporeal Membrane Oxygenation (ECMO) System Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Extra Corporeal Membrane Oxygenation (ECMO) System Market.

Available Customizations:

Global Extra Corporeal Membrane Oxygenation (ECMO) System market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Modality (Veno-Arterial (VA), Veno-Venous (VV), Others)
  • 5.2.2. By Application (Respiratory Applications, Cardiac Applications, Extracorporeal Cardiopulmonary Resuscitation (ECPR))
  • 5.2.3. By End-User (Hospitals & Clinics, Ambulatory Care Centers, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Modality
  • 6.2.2. By Application
  • 6.2.3. By End-User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Modality
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End-User
  • 6.3.2. Canada Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Modality
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End-User
  • 6.3.3. Mexico Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Modality
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End-User

7. Europe Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Modality
  • 7.2.2. By Application
  • 7.2.3. By End-User
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Modality
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End-User
  • 7.3.2. United Kingdom Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Modality
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End-User
  • 7.3.3. Italy Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecasty
      • 7.3.3.2.1. By Modality
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End-User
  • 7.3.4. France Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Modality
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End-User
  • 7.3.5. Spain Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Modality
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End-User

8. Asia-Pacific Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Modality
  • 8.2.2. By Application
  • 8.2.3. By End-User
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Modality
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End-User
  • 8.3.2. India Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Modality
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End-User
  • 8.3.3. Japan Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Modality
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End-User
  • 8.3.4. South Korea Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Modality
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End-User
  • 8.3.5. Australia Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Modality
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End-User

9. South America Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Modality
  • 9.2.2. By Application
  • 9.2.3. By End-User
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Modality
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End-User
  • 9.3.2. Argentina Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Modality
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End-User
  • 9.3.3. Colombia Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Modality
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End-User

10. Middle East and Africa Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Modality
  • 10.2.2. By Application
  • 10.2.3. By End-User
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Modality
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End-User
  • 10.3.2. Saudi Arabia Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Modality
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End-User
  • 10.3.3. UAE Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Modality
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End-User

11. Market Dynamics

• 11.1. Drivers & Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Extra Corporeal Membrane Oxygenation (ECMO) System Market: SWOT Analysis

14. Competitive Landscape

• 14.5.1. LivaNova (Alung Technologies Inc.)
• 14.5.2. Eurosets
• 14.5.3. Getinge AB
• 14.5.4. Medtronic PLC
• 14.5.5. Microport Scientific Corporation
• 14.5.6. Nipro Medical Corporation
• 14.5.7. Terumo Medical Corporation
• 14.5.8. Abbott Laboratories
• 14.5.9. Fresenius Medical Care Company

15. Strategic Recommendations

16. About Us & Disclaimer